CD96 and hepatocellular carcinoma: Patients with hepatocellular carcinoma that present reduced disease-free survival have dysfunctional (exhausted) TINK with a higher frequency of CD96+ cells and increased expression of CD96, but blockade of CD96 restores NK cell-mediated effector functions (190).